Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Continuation Study of the Human Anti-TNF Antibody D2E7 Administered as a Subcutaneous Injection in Patients With Rheumatoid Arthritis

NCT00195650 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00195650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00195650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Continuation Study of the Human Anti-TNF Antibody D2E7 Administered as a Subcutaneous Injection in Patients With Rheumatoid Arthritis
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2000
Completion date
May 31, 2011
Enrollment
846 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis